Clinical trial
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)
NCT00031395 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 1999
- Completion date
- June 30, 2007
- Enrollment
- 122 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.